AstraZeneca buys Chinese Gracell Biotechnologies for $1.2bn
Pharmaceutical giant Astrazeneca with CEO Pascal Soriot wants to take over the Chinese company Gracell Biotechnologies in order to strengthen its...
miRNA specialist Resalis Therapeutics Srl raises €10m in Series A financing
Existing investors including Claris Ventures and angel investors participated in the financing The proceeds will be used to initiate and complete the...
Bioplastics production capacity to quadruple by 2028
Global production capacity for bioplastics will almost quadruple within the next five years, according to estimates of the Nova Institute on behalf...
Curve Therapeutics raises £40.5m in Series A financing
New investors Columbus Venture Partners and British Patient Capital and founding investor Advent Life Sciences as well as seed investor Epidarex...
Researcher find potential target for atherosclerosis
Researchers have found a new way to reverse atherosclerotic plaque formation at the early stages. In Nature Cardiovascular Research, Alma...
Mogu Srl raises €11m to scale mycelium technology
Kering Ventures, and Progress Tech Transfer also participated in the €11m financing of Mogu Srl, which will change its company name to SQIM Srl. The...
Swiss vaccine developer Limma Tech get CARB-X grant
LimmaTech said, it will use the grant to advance preclinical development of its hexavalent vaccine candidate targeting Neisseria gonorrheae. Using...